CIAS
RMD icon

Capital Investment Advisory Services’s ResMed RMD Stock Holding History

Capital Investment Advisory Services’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-488
Closed -$66K – 1099
2019
Q3 		$66K Hold
488
– – 0.02% 494
2019
Q2 		$60K Hold
488
– – 0.02% 511
2019
Q1 		$51K Sell
488
-48
-9% -$4.95K 0.02% 481
2018
Q4 		$61K Buy
+536
New +$57.4K 0.03% 418

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Investment Advisory Services's RMD Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of ResMed (RMD) in Q4 2019, closing a stake of 488 shares — an estimated $66K sold.

Capital Investment Advisory Services first reported a position in RMD in Q4 2018 and held it in 4 quarters. The position peaked at $66K in Q3 2019. 559 funds tracked by Wall St. Rank hold RMD as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining ResMed position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 488 ResMed shares in Q4 2019, an estimated $66K.
  • Capital Investment Advisory Services first reported a position in ResMed in Q4 2018 and held it in 4 quarters.
  • Capital Investment Advisory Services's ResMed position peaked at $66K in Q3 2019.
  • 559 funds tracked by Wall St. Rank held ResMed as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.